- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Current or Recent History of Atrial Fibrillation in Czechia
Total 11 results
-
University Hospital OstravaRecruiting
-
University Hospital OstravaRecruitingPersistent Atrial Fibrillation | Recurrent Atrial FibrillationCzechia
-
Acutus MedicalCompletedRecurrent Atrial FibrillationUnited Kingdom, Netherlands, Germany, Canada, Czechia, Belgium
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Nanostim, Inc.UnknownAtrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) Block | Normal Sinus Rhythm With 2 or 3° AV or BBB Block | Sinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP FindingsGermany, Netherlands, Czech Republic
-
Charles University, Czech RepublicUnknownAtrial Fibrillation | Restore of Sinus Rhythm | Post-Operative ComplicationsCzech Republic
-
Medtronic BRCCompletedAtrial Fibrillation | Risk of Cardiac ArrhythmiasNetherlands, Germany, Austria, Belgium, Canada, Czech Republic, Russian Federation, Slovakia
-
BayerTerminatedAtrial Fibrillation | Prevention of Stroke or Systemic EmbolismCanada, United States, Israel, Korea, Republic of, China, Taiwan, Belgium, Australia, Singapore, Malaysia, Slovakia, United Kingdom, Czechia, Latvia, Japan, Brazil, Lithuania, Germany, France, Sweden, Turkey, Switzerland, Estonia, Bul... and more
-
AmgenCompletedMetastatic or Recurrent Squamous Cell Carcinoma of Head and NeckUnited States, Belgium, Czechia, Spain, Austria, France, Lithuania, Puerto Rico, Slovakia
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia